Circ_nuclear factor I X (circNfix) attenuates pressure overload-induced cardiac hypertrophy via regulating miR-145-5p/ATF3 axis

References

• Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65(1):45–79.
   PubMedGoogle Scholar
• Zhang M, Cheng K, Chen H, et al. MicroRNA-27 attenuates pressure overload-induced cardiac hypertrophy and dysfunction by targeting galectin-3. Arch Biochem Biophys. 2020;689:108405.
   PubMed Web of Science ®Google Scholar
• Zhu L, Li C, Liu Q, et al. Molecular biomarkers in cardiac hypertrophy. J Cell Mol Med. 2019;23(3):1671–1677.
   PubMed Web of Science ®Google Scholar
• Heineke J, Kempf T, Kraft T, et al. Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophy. Circulation. 2003;107(10):1424–1432.
   PubMed Web of Science ®Google Scholar
• Yuan L, Qiu L, Ye Y, et al. Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway. J Cell Mol Med. 2018;22(9):4292–4303.
   PubMed Web of Science ®Google Scholar
• Kang YJ. Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden death. Toxicol Pathol. 2006;34(1):58–66.
   PubMed Web of Science ®Google Scholar
• Sugiyama A, Okada M, Yamawaki H. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats. Eur J Pharmacol. 2020;871:172849.
   PubMed Web of Science ®Google Scholar
• Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006;114(15):1633–1644.
   PubMed Web of Science ®Google Scholar
• Tao L, Bei Y, Zhang H, et al. Exercise for the heart: signaling pathways. Oncotarget. 2015;6(25):20773–20784.
   PubMedGoogle Scholar
• Abel ED, Doenst T. Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc Res. 2011;90(2):234–242.
   PubMed Web of Science ®Google Scholar
• Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol. 2016;97:245–262.
   PubMed Web of Science ®Google Scholar
• Li H, Xu JD, Fang XH, et al. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc Res. 2020;116(7):1323–1334.
   PubMed Web of Science ®Google Scholar
• Hirt MN, Sörensen NA, Bartholdt LM, et al. Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic Res Cardiol. 2012;107(6):307.
   PubMed Web of Science ®Google Scholar
• Voelter-Mahlknecht S. Epigenetic associations in relation to cardiovascular prevention and therapeutics. Clin Epigenetics. 2016;8:4.
   PubMed Web of Science ®Google Scholar
• Wehbe N, Nasser SA, Pintus G, et al. MicroRNAs in cardiac hypertrophy. Int J Mol Sci. 2019;20(19):4714.
   PubMed Web of Science ®Google Scholar
• Zhang W, Xu W, Feng Y, et al. Non-coding RNA involvement in the pathogenesis of diabetic cardiomyopathy. J Cell Mol Med. 2019;23(9):5859–5867.
   PubMed Web of Science ®Google Scholar
• Boon RA, Dimmeler S. MicroRNAs in myocardial infarction. Nat Rev Cardiol. 2015;12(3):135–142.
   PubMed Web of Science ®Google Scholar
• Eltzschig HK, Eckle T. Ischemia and reperfusion–from mechanism to translation. Nat Med. 2011;17(11):1391–1401.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
   PubMed Web of Science ®Google Scholar
• Patop IL, Wüst S, Kadener S. Past, present, and future of circRNAs. Embo J. 2019;38(16):e100836.
   PubMed Web of Science ®Google Scholar
• Shen L, Bai Y, Han B, et al. Non-coding RNA and neuroinflammation: implications for the therapy of stroke. Stroke Vasc Neurol. 2019;4(2):96–98.
   PubMedGoogle Scholar
• Jae N, Heumuller AW, Fouani Y, et al. Long non-coding RNAs in vascular biology and disease. Vascul Pharmacol. 2019;114:13–22.
   PubMed Web of Science ®Google Scholar
• Greco S, Cardinali B, Falcone G, et al. Circular RNAs in muscle function and disease. Int J Mol Sci. 2018;19(11):3454.
   Web of Science ®Google Scholar
• Qu S, Zhong Y, Shang R, et al. The emerging landscape of circular RNA in life processes. RNA Biol. 2017;14(8):992–999.
   PubMed Web of Science ®Google Scholar
• Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148.
   PubMed Web of Science ®Google Scholar
• Szabo L, Morey R, Palpant NJ, et al. Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development. Genome Biol. 2015;16(1):126.
   PubMed Web of Science ®Google Scholar
• Wang K, Long B, Liu F, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur Heart J. 2016;37(33):2602–2611.
   PubMed Web of Science ®Google Scholar
• Huang S, Li X, Zheng H, et al. Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation. 2019;139(25):2857–2876.
   PubMed Web of Science ®Google Scholar
• Xu X, Wang J, Wang X. Silencing of circHIPK3 inhibits pressure overload-induced cardiac hypertrophy and dysfunction by sponging miR-185-3p. Drug Des Devel Ther. 2020;14:5699–5710.
   PubMed Web of Science ®Google Scholar
• Dudekula DB, Panda AC, Grammatikakis I, et al. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13(1):34–42.
   PubMed Web of Science ®Google Scholar
• Jiang F, Shen XB. miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA. Neoplasma. 2019;66(6):879–886.
   PubMed Web of Science ®Google Scholar
• Peng W, Li J, Chen R, et al. Upregulated METTL3 promotes metastasis of colorectal cancer via miR-1246/SPRED2/MAPK signaling pathway. J Exp Clin Cancer Res. 2019;38(1):393.
   PubMed Web of Science ®Google Scholar
• Shao L, He Q, Liu Y, et al. UPF1 regulates the malignant biological behaviors of glioblastoma cells via enhancing the stability of Linc-00313. Cell Death Dis. 2019;10(9):629.
   PubMedGoogle Scholar
• Wang Z, Xu Y, Wang M, et al. TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice. EBioMedicine. 2018;36:54–62.
   PubMed Web of Science ®Google Scholar
• Altesha MA, Ni T, Khan A, et al. Circular RNA in cardiovascular disease. J Cell Physiol. 2019;234(5):5588–5600.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang Y, Ge Z, et al. GDF11 attenuated ANG II-induced hypertrophic cardiomyopathy and expression of ANP, BNP and beta-MHC through down- regulating CCL11 in mice. Curr Mol Med. 2018;18(10):661–671.
   PubMed Web of Science ®Google Scholar
• Yang MH, Wang H, Han SN, et al. Circular RNA expression in isoproterenol hydrochloride-induced cardiac hypertrophy. Aging (Albany NY). 2020;12(3):2530–2544.
   PubMedGoogle Scholar
• Garikipati VNS, Verma SK, Cheng Z, et al. Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis. Nat Commun. 2019;10(1):4317.
   PubMed Web of Science ®Google Scholar
• Wu F, Han B, Wu S, et al. Circular RNA TLK1 aggravates neuronal injury and neurological deficits after ischemic stroke via miR-335-3p/TIPARP. J Neurosci. 2019;39(37):7369–7393.
   PubMed Web of Science ®Google Scholar
• Yu Q, Kou W, Xu X, et al. FNDC5/Irisin inhibits pathological cardiac hypertrophy. Clin Sci (Lond). 2019;133(5):611–627.
   PubMed Web of Science ®Google Scholar
• Bernardo BC, Weeks KL, Pretorius L, et al. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther. 2010;128(1):191–227.
   PubMed Web of Science ®Google Scholar
• Ding C, Wu Z, You H, et al. CircNFIX promotes progression of glioma through regulating miR-378e/RPN2 axis. J Exp Clin Cancer Res. 2019;38(1):506.
   PubMed Web of Science ®Google Scholar
• Lu J, Zhu Y, Qin Y, et al. CircNFIX acts as a miR-212-3p sponge to enhance the malignant progression of non-small cell lung cancer by up-regulating ADAM10. Cancer Manag Res. 2020;12:9577–9587.
   PubMed Web of Science ®Google Scholar
• Cheng J, Nie D, Li B, et al. CircNFIX promotes progression of pituitary adenoma via CCNB1 by sponging miR-34a −5p. Mol Cell Endocrinol. 2021;525:111140.
   PubMed Web of Science ®Google Scholar
• Chen H, Cai K. DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p. In Vitro Cell Dev Biol Anim. 2020;56(4):286–295.
   PubMed Web of Science ®Google Scholar
• Liu BL, Cheng M, Hu S, et al. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy. Biomed Pharmacother. 2018;108:1347–1356.
   PubMed Web of Science ®Google Scholar
• Xu CN, Kong LH, Ding P, et al. Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway. Biochim Biophys Acta Mol Basis Dis. 2020;1866(10):165848.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wu D, Zhang X, et al. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling. Gene. 2014;536(2):225–231.
   PubMed Web of Science ®Google Scholar
• Han J, Li S, Feng Y, et al. A novel circular RNA (hsa_circ_0059930)-mediated miRNA-mRNA axis in the lipopolysaccharide-induced acute lung injury model of MRC-5 cells. Bioengineered. 2021;12(1):1739–1751.
   PubMed Web of Science ®Google Scholar
• Gao Q, Liu Q, Chen H. Circular RNA hsa_circ_0000117 accelerates the proliferation and invasion of gastric cancer cells by regulating the microRNA-337-3p/signal transducer and activator of transcription 3 axis. Bioengineered. 2021;12(1):1381–1390.
   PubMed Web of Science ®Google Scholar
• Jadhav K, Zhang Y. Activating transcription factor 3 in immune response and metabolic regulation. Liver Res. 2017;1(2):96–102.
   PubMedGoogle Scholar
• Schoch S, Cibelli G, Magin A, et al. Modular structure of cAMP response element binding protein 2 (CREB2). Neurochem Int. 2001;38(7):601–608.
   PubMed Web of Science ®Google Scholar
• Lee JM, Han HS, Jung YS, et al. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes. J Biol Chem. 2018;293(34):13125–13133.
   PubMed Web of Science ®Google Scholar
• Koren L, Elhanani O, Kehat I, et al. Adult cardiac expression of the activating transcription factor 3, ATF3, promotes ventricular hypertrophy. PLoS One. 2013;8(7):e68396.
   PubMed Web of Science ®Google Scholar
• Li Y, Li Z, Zhang C, et al. Cardiac fibroblast-specific activating transcription factor 3 protects against heart failure by suppressing MAP2K3-p38 signaling. Circulation. 2017;135(21):2041–2057.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang Y, Yan S, et al. Effect of testosterone on the proliferation and collagen synthesis of cardiac fibroblasts induced by angiotensin II in neonatal rat. Bioengineered. 2017;8(1):14–20.
   PubMed Web of Science ®Google Scholar
• Shi JY, Chen C, Xu X, et al. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy. Acta Physiol (Oxf). 2019;227(2):e13323.
   PubMed Web of Science ®Google Scholar